Newsroom

COPENHAGEN, Denmark--(BUSINESS WIRE)--Keepit, the only independent, cloud-native data protection and recovery provider, proudly announced today that CRN UK—a brand of The Channel Company—has selected Alex Walsh and Cyril VanAgt for inclusion on the prestigious 2026 CRN® Channel Leaders EMEA list. This annual recognition celebrates IT vendor and distribution executives who are shaping channel strategy and driving innovation and partnership across the industry. Keepit operates a 100 percent chann...

TOKYO--(BUSINESS WIRE)--The East Japan Railway Foundation for Cultural Innovation announces the opening of MoN Takanawa: The Museum of Narratives on March 28, 2026. Located within TAKANAWA GATEWAY CITY near Shinagawa Station—a major transportation hub with direct railway access to Haneda and Narita airports—MoN Takanawa is a new cultural hub featuring a striking exterior designed by KENGO KUMA & ASSOCIATES. As an “Experimental Museum,” MoN Takanawa presents cross-disciplinary programs spann...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 26.03.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 9,995,234.93 22.212  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 26.03.2026 GMAY.LN IE000P0FL8E3 900,002.00 USD 34,151,326.30 37.946  ...

北京--(BUSINESS WIRE)--（ビジネスワイヤ） -- バイオサイトジェン （バイオサイトジェン、上海証券取引所：688796、香港証券取引所：02315）は、革新的な技術で新規抗体医薬品の研究開発を推進するバイオテクノロジー企業です。同社はこのたび、パートナーであるNEOK Bio, Inc.が、固形腫瘍を対象とするEGFR/MUC1標的ADCプログラムNEOK002について、米国食品医薬品局（FDA）から治験薬（IND）申請の承認を取得したことを発表しました。NEOK Bioは2026年第2四半期に第1相臨床試験を開始し、2027年に初期データを報告する予定です。 今回のIND承認は、NEOK Bioが開発し、バイオサイトジェンが開発した二重特異性抗体をベースに2024年にライセンス供与されたEGFR/MUC1標的ADC候補であるNEOK002にとって重要なマイルストーンとなります。NEOK Bioによると、NEOK002は固形腫瘍を対象に開発が進められており、いずれか単一の標的に対する単一特異性ADCアプローチと比較して、差別化された有効性と安全性を提供できる可能性...

中國北京--(BUSINESS WIRE)--(美國商業資訊)-- 以創新技術驅動新藥研發的國際性生物科技公司百奧賽圖（北京）醫藥科技股份有限公司（以下簡稱「百奧賽圖」，SSE: 688796；HKEX: 02315）今日宣布，其合作夥伴NEOK Bio, Inc.近日獲得美國食品藥物管理局（FDA）對其試驗中新藥NEOK002的新藥臨床試驗申請（IND）核准。NEOK002是一款標靶作用於EGFR/MUC1的抗體藥物複合體（ADC），擬用於實質腫瘤治療。NEOK Bio計畫於2026年第二季啟動第一期臨床試驗，並可望於2027年公布初步臨床資料。 此次IND獲准代表NEOK002專案取得重要里程碑進展。NEOK002以百奧賽圖自主開發並於2024年對外授權的雙特異性抗體為基礎建構，由NEOK Bio進一步推進ADC藥物開發。根據NEOK Bio披露，NEOK002針對實質腫瘤治療開發，相較于僅標靶作用於單一抗原的ADC藥物，可望在療效與安全性方面展現差異化優勢。 百奧賽圖董事長兼執行長沈月雷博士表示：「我們欣然看到合作專案推進至這一重要階段。此次里程碑的達成，進一步驗證了以RenLi...

LONDON--(BUSINESS WIRE)--Aperture Investors, an alternative asset manager and part of Generali Investments, is pleased to announce that the Aperture Investors European Innovation Fund has been recognized at the LSEG Lipper Fund Awards 2026 Europe, earning top honors in the Alternative Long/Short Equity Europe category. The Aperture Investors European Innovation Fund, EX EUR Class (SICAV), was named best fund in Lipper’s Alternative Long/Short Equity Europe category over the trailing three- and...

WARSAW, Poland--(BUSINESS WIRE)--The Polish Investment and Trade Agency (PAIH) has named Ascend Elements’ Project Apex 2 its Manufacturing Investment of the Year, focused on the company’s development of the EU’s first fully integrated battery materials refining center that will turn spent lithium‑ion batteries into new, low‑carbon cathode materials using its Hydro‑to‑Cathode® technology. The Republic of Poland has granted Ascend Elements USD 320 million (approximately 1.22 billion PLN) to advan...

LONDON & FRANKFURT, Germany--(BUSINESS WIRE)--European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chos...

NEUSS, Germany--(BUSINESS WIRE)--Tineco, a global leader in intelligent floor care solutions, announces that Euromonitor International has recognised the company as the world’s leading brand in the household wet & dry vacuum cleaner segment for the fourth consecutive year*. The recognition by one of the world’s leading independent market research providers highlights Tineco’s sustained leadership and growth momentum within the global smart home category. In recent years, Tineco has played a...